Temasek Holdings saw its net portfolio value reach S$308 billion ($235 billion) as the Singapore government-controlled investment fund stepped up its investment activity in the 12 months ended March 2018.
Temasek deployed S$29 billion in 2018, significantly higher than the $16 billion invested in 2017 but around the same level as the two years before that. Realizations remained low, however, with S$16 billion...
Motilal Oswal Private Equity (MOPE) and healthcare-focused GP Invascent Capital have invested in Indian pharmaceutical developer Symbiotec Pharmalab, providing an exit for Actis Capital.
The transformation of Manuka Health from loosely run family affair into professional segment leader helped organize a cottage industry into big business
A selection of the key fundraising, investment and exit events - presented in chronological order - from the past 12 months
Fuyoukache, a Chinese online truck logistics platform, has raised $170 million in a Series D round led by a Bank of China investment unit and Matrix Partners China. Prospect Avenue Capital also participated.